VALEANT PHARMACEUTICALS INTERNATIONAL·4

May 13, 7:29 PM ET

STEFANO STEPHEN F. 4

4 · VALEANT PHARMACEUTICALS INTERNATIONAL · Filed May 13, 2009

Insider Transaction Report

Form 4
Period: 2009-05-12
Transactions
  • Purchase

    Common Stock

    2009-05-12$19.78/sh+2,000$39,5632,227 total
  • Award

    Common Stock

    2009-05-12+1402,367 total
  • Award

    Common Stock

    2009-05-12+6,5468,913 total
Footnotes (2)
  • [F1]Represents restricted stock units in lieu of cash for Board and Commitee meeting fees, pursuant to the election of the Board member, which may be settled only in common stock.
  • [F2]Represents award of restricted stock units pursuant to the 2006 Equity Incentive Plan, which may be settled only in common stock.

Documents

2 files
  • 4
    edgardoc.xmlPrimary

    PRIMARY DOCUMENT

  • EX-24

    EDGAR SUPPORTING DOCUMENT